Liraglutide pierdere în greutate pcos

liraglutide pierdere în greutate pcos

Participants with diabetes will be excluded - Willing to use effective contraception consistently during therapy which is defined as: - an intrauterine device, tubal sterilization, or male partner vasectomy, or - combination of two barrier methods with one being male condom.

Abdominal adiposity waist circumference [WC] [Baseline to week 30] Treatment effect on loss of abdominal adiposity 4.

liraglutide pierdere în greutate pcos cum să pierdeți în greutate atunci când este menstruat

Central adiposity waist-to height ratio [WHtR] [Baseline to week 30] Treatment effect on loss of central adiposity 5. Menstruation frequency [Baseline to week 30] Treatment impact on normalization of cycle frequency 9. Change in glycemic responses from a glucose challenge [Baseline to week 30] Treatment effect on fasting and 2 hour glucose during an oral glucose tolerance test OGTT Surrogate measures of insulin sensitivity [Baseline to week 30] Treatment effect on insulin sensitivity indices determined from fasting and OGTT measures Pancreatic beta cell compensatory function measures [Baseline to week 30] Treatment effect on improving first phase insulin secretion Oral disposition insulin secretion-sensitivity index [Baseline to week 30] Treatment effect on improving insulin action modeled from a 2 hour OGTT Systolic and diastolic blood pressure BP [Baseline to week 30] Treatment impact on reducing blood pressure Alte măsuri de rezultat 1.

liraglutide pierdere în greutate pcos mercy johnson pierdere în greutate

Safety laboratory measures creatinine liraglutide pierdere în greutate pcos estimated glomerular filtration rate [eGFR] [Baseline to week 30] Determine if treatment has any adverse impact on renal function as evaluated by blood levels of creatinine and estimated creatinine clearance eGFR 2.

Safety laboratory measures aspartate transaminase [AST levels [Baseline to week 30] Determine if treatment has any adverse impact on liver function as evaluated by AST enzyme concentration 3.

liraglutide pierdere în greutate pcos pierde 5 kg de grăsime corporală

Safety laboratory measures alanine transaminase [ALT] levels [Baseline to week 30] Determine if treatment has any adverse impact on liver function as evaluated by ALT enzyme concentrations 4.

Pregnancy tests laboratory measures and home tests [Baseline to week 30] Confirm patients are not pregnant while under treatment.

liraglutide pierdere în greutate pcos poți să pierzi greutatea pe prilosec

Informațiiimportante